NIH Public Access Policy: Overview

•Download as PPTX, PDF•

1 like•306 views

This document provides an overview of the National Institutes of Health (NIH) Public Access Policy, which requires investigators funded by NIH to submit final peer-reviewed manuscripts to PubMed Central upon acceptance for publication, to be made publicly available no later than 12 months after official publication. It defines a PubMed Identification Number (PMID) and PubMed Central Identification Number (PMCID), and outlines the policy's applicability and compliance responsibilities. The principal investigator is responsible for ensuring the final manuscript is submitted through one of four methods: publisher submission to PubMed Central, submission to NIH's manuscript submission system with publisher permission, direct submission to NIH's system, or publisher submission to NIH's system.

Health & Medicine

NIH Public Access Policy
Overview
Norris Medical Library
Education and Research Services
(323) 442-1483
medlib@usc.edu

Outline
• What is a PMID? What is a PMCID?
• What is the National Institutes of Health (NIH)
Public Access Policy?
• What are the options for complying with the NIH
Public Access Policy?
• Who is responsible for this compliance?
• How can a manuscript be submitted to PubMed
Central?
• How do I locate more information about this
process?
norris.usc.libguides.com/nihcompliance

PMID = PubMed Identification Number
• Unique number assigned to each article indexed to
PubMed
• Requires no particular effort from the author
norris.usc.libguides.com/nihcompliance

PMID = PubMed Identification Number
norris.usc.libguides.com/nihcompliance

PMCID = PubMed Central Identification Number
• PubMed Central
• Free full-text archive of the National Institute of Health’s
National Library of Medicine
• Unique number assigned to each article submitted to
PubMed Central
• Verifies that articles have been submitted in
compliance to NIH Public Access Policy mandate
norris.usc.libguides.com/nihcompliance

PMCID = PubMed Central Identification Number
norris.usc.libguides.com/nihcompliance

2008 Consolidated Appropriations Act
"The Director of the National Institutes of Health
shall require that all investigators funded by the NIH
submit or have submitted for them to the National
Library of Medicine’s PubMed Central an electronic
version of their final, peer-reviewed manuscripts
upon acceptance for publication, to be made publicly
available no later than 12 months after the official
date of publication: Provided, that the NIH shall
implement the public access policy in a manner
consistent with copyright law.”
norris.usc.libguides.com/nihcompliance

Applicability
• Any manuscript that:
• Is peer reviewed;
• And, is accepted for publication in a journal1 on or after
April 7, 2008;
• And, arises from:
• Any direct funding2 from an NIH grant or cooperative
agreement active in Fiscal Year 2008 or beyond, or;
• Any direct funding from an NIH contract signed on or after April
7, 2008, or;
• Any direct funding from the NIH Intramural Program, or;
• An NIH employee.
norris.usc.libguides.com/nihcompliance

Who is responsible for compliance?
The principal investigator (PI)
norris.usc.libguides.com/nihcompliance

Method A or B
norris.usc.libguides.com/nihcompliance
Adapted from Duke University Medical Center Library & Archives Compliance Process Diagram:
http://guides.mclibrary.duke.edu/nihpapcompliance
Final Peer
Reviewed
Manuscript
PubMed Central
(NIH/NLM public access archive)
Method A or B:
Publisher submits
published article

Method C
norris.usc.libguides.com/nihcompliance
Adapted from Duke University Medical Center Library & Archives Compliance Process Diagram:
http://guides.mclibrary.duke.edu/nihpapcompliance
Final Peer
Reviewed
Manuscript
PubMed Central
(NIH/NLM public access archive)
Method A or B:
Publisher submits
published article NIHMS
(National Institutes of
Health Manuscript
Submission system)
Method C:
PI/Author submits
final manuscript to
NIHMS
PI/Author approves
submission

Method D
norris.usc.libguides.com/nihcompliance
Adapted from Duke University Medical Center Library & Archives Compliance Process Diagram:
http://guides.mclibrary.duke.edu/nihpapcompliance
Final Peer
Reviewed
Manuscript
PubMed Central
(NIH/NLM public access archive)
Method A or B:
Publisher submits
published article NIHMS
(National Institutes of
Health Manuscript
Submission system)
Method C:
PI/Author submits
final manuscript to
NIHMS
PI/Author approves
submission
Method D:
Publisher submits
final manuscript
to NIHMS

More Information
• NIH Public Access Policy:
publicaccess.nih.gov/
• Policy Details:
publicaccess.nih.gov/policy.htm
• Submission Methods:
publicaccess.nih.gov/submit_process.htm
• NIH Manuscript Submission System Help:
nihms.nih.gov/help/
norris.usc.libguides.com/nihcompliance

The document discusses the NIH Public Access Mandate and Open Access. It provides details on the NIH policy requiring researchers to submit final peer-reviewed manuscripts resulting from NIH funding to PubMed Central within 12 months of publication. It outlines who is responsible for compliance and the different methods for complying. It also distinguishes between public access, which is specific to NIH-funded material, and open access, which aims to make scholarly work freely available to all.

NIH Public Access Policy: What You and Your Researchers Need To Know

University of Michigan Taubman Health Sciences Library

The National Institutes of Health (NIH) requires researchers receiving NIH funding to submit the final peer-reviewed manuscripts of journal articles to PubMed Central upon acceptance for publication. This policy aims to provide public access to publicly funded research and advance science. It applies to all research funded by the NIH after April 7, 2008. Researchers and their institutions are responsible for ensuring compliance with this policy.

Public Access Short Presentation Ucsf Modify

Marcus Banks

The document provides an overview of the NIH Public Access Policy, which requires researchers receiving NIH funding to submit final peer-reviewed manuscripts to PubMed Central upon acceptance for publication. It discusses the goals of increasing access to taxpayer-funded research and complying with copyright law. It also outlines requirements for compliance, such as submitting manuscripts to NIHMS or including PMCIDs in citations when referring to applicable articles.

NIH Public Access Policy

UT MD Anderson Cancer Center Research Medical Library

This document discusses the NIH Public Access Policy and how to comply using My NCBI and the RPPR. It provides an overview of the policy, how to associate publications with grants in My NCBI and the RPPR, and assistance available for MD Anderson faculty and staff. Key steps include addressing copyright, depositing papers in PubMed Central, adding citations to My Bibliography, and associating publications with grants in reporting. The Research Medical Library can help with depositing papers and understanding the policy's requirements.

NIH Public Access Policy at UCLA - Fall 2012

lmfederer

Sra Oa Sparc

BioMedCentral

The document discusses the National Institutes of Health (NIH) Public Access Policy, which mandates that investigators funded by NIH submit final peer-reviewed manuscripts to PubMed Central upon acceptance for publication, to be made publicly available no later than 12 months after official publication date. It provides details on policy requirements, author responsibilities, and submission procedures to comply with the policy.

Navigating the NIH Public Access Policy

Sarah Young

Sra Oa Nih

BioMedCentral

The document summarizes the NIH public access policy and its implications for various stakeholders on university campuses. It discusses how the policy aims to improve access to NIH-funded research. It outlines the requirements for compliance, including ensuring grantees have rights to deposit manuscripts and setting appropriate embargo periods. It describes roles and opportunities for researchers, administrators, legal counsel, and librarians in supporting compliance and advancing open access more broadly.

The National Institutes of Health has a public access policy that requires researchers who receive NIH funding to submit final peer-reviewed manuscripts to PubMed Central upon acceptance for publication. The policy summary provides details on complying with the policy, including determining if a publication is applicable, addressing copyright, submitting manuscripts to the NIH Manuscript Submission System, and showing compliance in grant applications and progress reports by including PubMed Central IDs or NIH Manuscript Submission IDs in citations.

NIH Public Access Policy: After You Publish

lynnkysh

This document provides information on tracking compliance with the NIH Public Access Policy after publication. It discusses using eRA Commons and NIH RePORTER to find grant information and publications. It also covers locating author agreements to ensure they allow submission to PubMed Central and examples of publisher policies, including straightforward language from Elsevier and less clear language from the American Journal of Public Health. Finally, it lists additional resources on the NIH Public Access Policy.

Oregon State University and NIH Open Access Policies (2014)

mboock

This document discusses Oregon State University's open access policy and how to comply with the National Institutes of Health public access policy. It provides an overview of green and gold open access. It describes the key points and requirements of OSU's open access policy, including depositing articles in the institutional repository. It also outlines the NIH policy's goals and requirements for depositing peer-reviewed articles from NIH-funded research in PubMed Central within 12 months of publication. Finally, it discusses the different methods for complying with the NIH policy, including publishing in certain journals, arranging publisher deposit, or depositing manuscripts directly through the NIH system.

NIH OA

lmbrand

The document discusses the NIH Public Access Policy which requires researchers receiving NIH funding to submit final peer-reviewed manuscripts to PubMed Central within 12 months of publication. It outlines who is responsible for compliance, when the policy applies, and the different methods for complying through journal submission or direct deposit. It also discusses the differences between public access which is mandated by NIH and open access which aims to make research freely available, as well as two main roads to open access - gold open access journals and green open access self-archiving.

NIH Public Access Policy

stephanieballard

The document summarizes the NIH Public Access Policy, which requires researchers who receive NIH funding to submit final peer-reviewed manuscripts to PubMed Central. It discusses how the policy benefits researchers, patients, and the public. It also outlines how libraries can help by advising authors on copyright issues, assisting with publisher agreements, and coordinating compliance efforts. The library's role is presented as helping relieve burdens on researchers while supporting open access to the biomedical literature.

NIH Public Access policy

stephanieballard

Pistoia Alliance conference April 2016: Robotics: Steve Rees

Pistoia Alliance

The document discusses the impact of robotics on drug discovery. It notes that automation allows researchers to do existing work at lower cost and higher quality, and also enables new processes that were previously not possible. Specifically, automation has helped scale up sample management and compound screening processes. Advances in robotics, miniaturization, and other technologies have been driven by factors like the omics revolution and increased target knowledge from structural biology. However, challenges for the future include managing large data sets and training scientists to work with robotic systems.

Demystifying the COMREC Processes and Procedures

Lucinda Manda-Taylor?

This document summarizes a presentation about the COMREC processes and procedures for research approval at a medical college in Malawi. It outlines the functions of COMREC, which include protecting human and animal subjects in research and promoting ethical research. It describes the submission procedures, requiring proposals to be submitted by the 1st of each month with a processing fee. It also summarizes the review process, categories of review, exemption criteria, elements of review including ethics and methodology, and application materials required. The goal is to demystify the COMREC research approval processes and procedures for faculty and students conducting research.

Shaw - Compliance Workflow, Tips and Complications

National Information Standards Organization (NISO)

COVID-19 and its implications for the scholarly communication system

Ludo Waltman

COVID-19 has implications for the scholarly communication system by affecting dissemination, accessibility, quality control, and findability of research. The pandemic led to a large increase in preprint submissions as researchers sought rapid dissemination of COVID-19 findings. Preprint servers helped make research widely accessible. While traditional peer review was bypassed, some preprints received rapid or post-publication peer review. Open access publishing also increased accessibility. The value of preprint servers and next-generation search technologies was demonstrated, but literature databases not covering preprints may lose value. COVID-19 provides a strong argument for open access and shows preprints can play an important role in biomedical research dissemination.

How UT Librarians Can Help You Secure (and Keep) NIH Funding

ScholarlyCommTenn

How to improve the acceptance of AltMetrics

uherb

This document discusses a breakout group at the CERN Workshop on Innovations in Scholarly Communication focused on altmetrics. The group aims to make recommendations to improve acceptance of altmetrics. Key issues to be discussed include methodology, data quality, stability, and reliability of altmetrics. Under each issue, questions are posed about how altmetrics measure various dimensions like quality and relevance, how to ensure consistent and verifiable data, and what infrastructure is needed to provide a stable altmetrics service.

Kuchinke Personalized Medicine tools for clinical research networks

Wolfgang Kuchinke

Personalized medicine for clinical trials networks. The p-medicine project is presented. It deals with the creation of an integrative infrastructure for Personalised Medicine, which aims to accelerate personalized medicine and personal clinical research. For this purpose p-medicine developed a comprehensive set of software tools, including ObTiMA data management system, Patient Empowerment Tool, data mining, data warehousing, biobank access, decision support, image annotation (DrEye) and simulation (Oncosimulator). Here we show the evaluation of some of the p-medicine tools for their suitablity to perform clinical trials. Is their usage conform with regulations and standards (GCP, GDPR, GAMP, computer system validation)? Can these tools be integrated into the existing systems (IT infrastructure / organisational framework) of an international clinical trials network (ECRIN)? To perform clinical trials, a legal and ethical framework based on international requirements and approved concepts for data security must be adopted. GCP (Good Clinical Practice) is such an international ethical and scientific quality standard for designing, recording and reporting trials that involve the participation of human subjects. Evaluation of usability of p-medicine software tools for clinical trials was done with two surveys: (1) survey of p-medicine tools in the ECRIN network and (2) p-medicine developer survey. The tool integration topics contained questions about the employment of the right Clinical Data Management System (CDMS) at the many ECRIN centres. There is competition between different solutions, like VISTA (EORTC) MACRO, secuTrial, RAVE, OpenClinica. CDMS should be usable for all types of trials and the usability in clinical trials must be demonstrated by integration of biobank access / safety functions. Only ObTiMA is able to specifically address the challenges of personal medicine clinical trials. The results of the evaluation was that there exists some compliance gaps for quality management during software development, no complete GCP compliance yet and the missing of a robust business model for software sustainability. To address the latter, a Reciprocal Integration approach was developed to integrate p-medicine tools into clinical research networks.

CanDIG Presentation at 5th GA4GH Plenary Day 2

Jonathan Dursi

The Canadian Distributed Infrastructure for Genomics (CanDIG) project aims to enable distributed analysis of genomic data across Canada while keeping data locally controlled. Over the next 4 years, CanDIG will build infrastructure to support interactive and batch analyses of national cohorts through APIs. Initial work involves supporting pediatric cancer and clinical trial projects, and improving performance, authentication, and standards. Future goals include expanding available analyses, integrating with other systems, and building interoperability.

Stevan Harnad: Open Access - Open Data: similarities and differences

"Open Access - Open Data" conference, 13th/14th December, 2010

Open Access (OA) means free online access to the 2.5 million articles published every year in the world's 25,000 peer-reviewed scholarly and scientific research journals. OA can be provided in two ways: To provide "Green OA," authors self-archive the final refereed drafts of their articles in their institutional OA repositories immediately upon acceptance for publication (by conventional, non-OA journals). To provide "Gold OA," authors publish their articles in OA journals that make all their articles free online immediately upon publication. (Sometimes a fee is charged to the author's institution for Gold OA.) Because of the benefits of OA (in terms of maximized visibility, accessibility, uptake, usage and impact) to research, researchers, their institutions and the taxpayers that fund them, institutions and funders worldwide are increasingly mandating (i.e. requiring) Green OA self-archiving. Gold OA publishing cannot be mandated by authors' institutions and funders, but universal Green OA self-archiving mandates may eventually lead to a global transition to Gold OA publishing; it depends on whether and how long subscriptions remain sustainable as the means of covering the costs of print and online publication; if subscriptions become unsustainable, authors' institutions will pay journal publishers for peer review out of a portion of their annual windfall subscription cancellation savings. Data-archiving cannot be mandated, because researchers must be allowed the exclusive right to mine their data they have collected if they wish; but as Green OA self-archiving grows, data-archiving too will grow, because of their natural complementarity and the power of global collaboration to accelerate and enhance research progress.

Open science from the current policy context to horizon europe webinar nov 2019

Alea López de San Román González

The document provides an overview of open science and Horizon Europe. Key points include: - Horizon Europe goes beyond open access to embrace open science as the default approach for publicly funded research. - It sets mandatory requirements for open access to publications and research data managed according to FAIR principles. - Open science will be further incentivized and rewarded through the evaluation process and rules for funding recipients. - Initiatives like the European Open Science Cloud aim to provide core services and infrastructure to support open science practices. - Several working groups are defining the roadmap and requirements to deliver an initial operational version of open science in the EU by the end of 2020.

Scholarly Publishing Expertise at the UT Libraries

ScholarlyCommTenn

Contextualized scientometrics: What's behind the numbers?

Ludo Waltman

This document discusses contextualized scientometrics and outlines an agenda for the scientometric community. It begins by showing bibliometric indicators for top Chinese universities and explores what factors influence these numbers through techniques like identifying research areas and topics in citation networks. It argues that scientometrics should focus on contextualization over representation by making diverse statistics and information available rather than basing decisions solely on indicators. Open data sources like the Initiative for Open Citations and Dimensions platform can help accomplish this by providing open metadata. The agenda calls on scientometricians to promote responsible use of indicators, support open data initiatives, use open sources in research, and support open metadata as authors and reviewers.

Borchardt, How Can Libraries be Involved in Altmetrics?

National Information Standards Organization (NISO)

20190527_Dietmar Lampert _ New indicators for Open Sciene

OpenAIRE

Presented by Dietmar Lampert (ZSI Research Policy and Development) during the OpenAIRE workshop "Research policy monitoring in the era of Open Science and Big Data" taking place in Ghent, Belgium on May 27th and 28th 2019 Day 1: Monitoring and Infrastructure for Open Science https://www.openaire.eu/research-policy-monitoring-in-the-era-of-open-science-and-big-data-the-what-indicators-and-the-how-infrastructures

NIHPAP Lecture, part 2 - Complying

University of Michigan Taubman Health Sciences Library

The document provides information on complying with the National Institutes of Health Public Access Policy, which requires that final peer-reviewed manuscripts resulting from NIH-funded research be submitted to PubMed Central upon acceptance for publication and made publicly available no later than 12 months after publication. The principal investigator is responsible for ensuring compliance even if they are not an author, and both the PI and their affiliated institution share responsibility.

NIH Public Access Policy, eRA Commons & My Bbiliography

University of Michigan Taubman Health Sciences Library

The document provides an overview of the National Institutes of Health (NIH) Public Access Policy, which requires researchers receiving NIH funding to submit final peer-reviewed manuscripts to PubMed Central within 12 months of publication. It discusses compliance with the policy and outlines the process for submitting articles to PubMed Central or PubMed, including determining applicability and addressing copyright. Guidelines for including PMCIDs or NIHMSIDs in citations for NIH applications and reports are also covered.

What's hot

National Institutes of Health Public Access Policy

University of Michigan Taubman Health Sciences Library

NIH Public Access Policy: After You Publish

lynnkysh

Oregon State University and NIH Open Access Policies (2014)

mboock

NIH OA

lmbrand

NIH Public Access Policy

stephanieballard

NIH Public Access policy

stephanieballard

Pistoia Alliance conference April 2016: Robotics: Steve Rees

Pistoia Alliance

Demystifying the COMREC Processes and Procedures

Lucinda Manda-Taylor?

Shaw - Compliance Workflow, Tips and Complications

National Information Standards Organization (NISO)

COVID-19 and its implications for the scholarly communication system

Ludo Waltman

How UT Librarians Can Help You Secure (and Keep) NIH Funding

ScholarlyCommTenn

How to improve the acceptance of AltMetrics

uherb

Kuchinke Personalized Medicine tools for clinical research networks

Wolfgang Kuchinke

CanDIG Presentation at 5th GA4GH Plenary Day 2

Jonathan Dursi

Stevan Harnad: Open Access - Open Data: similarities and differences

"Open Access - Open Data" conference, 13th/14th December, 2010

Open science from the current policy context to horizon europe webinar nov 2019

Alea López de San Román González

Scholarly Publishing Expertise at the UT Libraries

ScholarlyCommTenn

Contextualized scientometrics: What's behind the numbers?

Ludo Waltman

Borchardt, How Can Libraries be Involved in Altmetrics?

National Information Standards Organization (NISO)

20190527_Dietmar Lampert _ New indicators for Open Sciene

OpenAIRE

What's hot (20)

National Institutes of Health Public Access Policy

NIH Public Access Policy: After You Publish

Oregon State University and NIH Open Access Policies (2014)

NIH OA

NIH Public Access Policy

NIH Public Access policy

Pistoia Alliance conference April 2016: Robotics: Steve Rees

Demystifying the COMREC Processes and Procedures

Shaw - Compliance Workflow, Tips and Complications

COVID-19 and its implications for the scholarly communication system

How UT Librarians Can Help You Secure (and Keep) NIH Funding

How to improve the acceptance of AltMetrics

Kuchinke Personalized Medicine tools for clinical research networks

CanDIG Presentation at 5th GA4GH Plenary Day 2

Stevan Harnad: Open Access - Open Data: similarities and differences

Open science from the current policy context to horizon europe webinar nov 2019

Scholarly Publishing Expertise at the UT Libraries

Contextualized scientometrics: What's behind the numbers?

Borchardt, How Can Libraries be Involved in Altmetrics?

20190527_Dietmar Lampert _ New indicators for Open Sciene

Similar to NIH Public Access Policy: Overview

NIHPAP Lecture, part 2 - Complying

University of Michigan Taubman Health Sciences Library

NIH Public Access Policy, eRA Commons & My Bbiliography

University of Michigan Taubman Health Sciences Library

NIHPAP Lecture, part 1 - About the Policy

University of Michigan Taubman Health Sciences Library

The document provides information about the National Institutes of Health Public Access Policy which requires that investigators funded by NIH submit electronic versions of their final peer-reviewed manuscripts to PubMed Central, a free archive of biomedical literature managed by the National Library of Medicine, to be made publicly available no later than 12 months after official publication. It describes PubMed Central, the NIH Manuscript Submission System which is used to deposit manuscripts, and compliance with the policy for NIH grant funding.

NIH Biosketch & Federal Public Access Policies

APLICwebmaster

The document discusses open access, public access, and biosketch policies from NIH. It explains the importance of journal articles and the differences between open access and public access models of publishing. The main points are that the NIH Public Access Policy requires authors to submit peer-reviewed publications from NIH-funded research to PubMed Central within 12 months of publication. Compliance is important because NIH can delay funding for non-compliance. The document outlines the steps for complying with the policy, including determining the submission method and proper citation of the PMCID.

Guide for My Bibliography and Compliance

Albert Einstein Cancer Center

The document discusses the NIH public access policy, which requires researchers receiving NIH funding to submit final peer-reviewed manuscripts to PubMed Central. It outlines the policy requirements, explains the four methods of compliance, and provides tips on how to locate PMCID numbers, configure EndNote, and get help from the library to ensure compliance. Potential issues like determining the appropriate manuscript version and locating NIHMS IDs are also addressed.

The NIH Public Access Policy and Compliance Requirements

unchealthscienceslibrary

The NIH Public Access Policy requires investigators funded by the NIH to submit final peer-reviewed manuscripts to PubMed Central upon acceptance for publication, to be made publicly available no later than 12 months after official publication date. The policy aims to advance science and improve public access. Effective July 1, 2013, NIH will delay processing awards if publications are not compliant and investigators must use My NCBI to enter publications into progress reports. My NCBI allows investigators to manage compliance by linking publications to specific awards.

NCCMT Spotlight Webinar: MetaQAT

The National Collaborating Centre for Methods and Tools

Interested in a tool to appraise all types of public health evidence? Do you appraise public health evidence? Are you interested in a single tool that can appraise many different types of evidence and study designs? Join us for a webinar to learn about the MetaQAT. This tool was developed by Public Health Ontario. How can the MetaQAT help you? Many different types of evidence and study designs may be used to answer a single public health question. The MetaQAT provides a single process that can be used to appraise these different types of evidence. This supports the use of evidence to formulate recommendations and develop public health actions. The MetaQAT consists of a four domain appraisal framework that includes relevance, reliability, validity, and applicability. A suite of design-specific companion tools are included to provide further guidance to assess validity of common designs. This webinar includes an overview of the MetaQAT by its developer, Dr. Laura Rosella, followed by a presentation from Dr. Catherine Bornbaum, who used the MetaQAT in conducting a systematic review. To see the summary statement of this tool developed by NCCMT, click here: http://www.nccmt.ca/resources/search/243 The National Collaborating Centre for Methods and Tools is funded by the Public Health Agency of Canada and affiliated with McMaster University. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada. NCCMT is one of six National Collaborating Centres (NCCs) for Public Health. The Centres promote and improve the use of scientific research and other knowledge to strengthen public health practices and policies in Canada.

NIH Public Access Policy: Ready to Publish

lynnkysh

This document provides information about the NIH Public Access Policy, which requires authors to submit final peer-reviewed manuscripts from NIH-funded research to PubMed Central no later than 12 months after publication. It discusses finding copyright transfer information, potential examples of publisher policies, and the four methods for submitting manuscripts to PubMed Central - which include submission by the publisher, author, or directly to NIH. Additional resources are also provided.

Applying research in public health

Professor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol

NIH Public Access Policy: You Received NIH Funding

lynnkysh

The document outlines the responsibilities of a primary investigator (PI) who receives NIH funding. The PI must act as a liaison between NIH and ensure publications acknowledge NIH funding and include required disclaimers. The PI is responsible for depositing manuscripts into PubMed Central and communicating NIH policy requirements to students, collaborators, and subcontractors on funded projects.

BIOMEDICAL .ppt

AnandKumar459862

BioMed Central is an independent publisher of peer-reviewed open access research journals. It launched its first journals in 2000 and now publishes over 150 open access journals across biology and medicine. All research articles published in BioMed Central journals are universally and freely accessible online. Authors retain copyright and grant anyone the right to use, reproduce or disseminate their work. Journal costs are covered by article processing charges typically paid by the author's funder or institution. BioMed Central has experienced rapid growth in submissions and readership, and many of its journals have received impact factors. It aims to make peer-reviewed scientific research available to all.

Community Training in Evidence Based Practice 3-28-13

The TMC Library

- The document outlines an agenda for a training on evidence-based practice resources. It will cover the basics of evidence-based practice, searching PubMed and other resources for literature, and obtaining information from local libraries. - The training will teach the 5 steps of evidence-based practice: assess the question, ask using PICO format, acquire evidence by searching resources, appraise the evidence found, and apply it. Attendees will learn how to search PubMed and other free resources and formulate searches using PICO. - Attendees will have time to practice searches in PubMed and other discussed resources to find both filtered and unfiltered evidence on a health topic of their choice.

NIH Public Access Policy - Neil Thakur (2007)

faflrt

Nih Public Access Policy

University of Michigan Taubman Health Sciences Library

1. The NIH Public Access Policy requires that investigators funded by NIH submit the final peer-reviewed manuscript from any NIH-funded research to PubMed Central upon acceptance for publication. 2. To comply, investigators should retain the right to deposit manuscripts in PubMed Central in their publication agreements. Manuscripts can be deposited directly or publishers may deposit on behalf of investigators. 3. The PMCID (PubMed Central identification number) from deposited manuscripts must be cited in all communications with NIH, such as grant applications and progress reports.

Analytical Methods for Systematic Review Support

Douglas Joubert

Gai Moore, Sax Institute

Sax Institute

This document summarizes different approaches used to effectively present evidence from research to policymakers. It discusses challenges policymakers face in using evidence, such as finding relevant research and interpreting research language. It then describes several methods used by organizations to help address these challenges, including providing easier access to research through summaries, syntheses, and online registries. The document examines these evidence presentation approaches used by organizations like NICE, Health Evidence, and Health Systems Evidence, highlighting their roles, products, and methods of dissemination. It concludes by reflecting on key learnings around being responsive to emerging evidence needs and using different lenses to analyze agencies' evidence needs.

RDAP14: OSTP Panel NIH’s Update Public Access

ASIS&T

NIH Public Access Policy May2008

iumedlibweb

The document discusses the key elements and requirements for complying with the NIH Public Access Policy, which requires investigators funded by NIH to submit final peer-reviewed manuscripts to PubMed Central upon acceptance for publication. The three main elements are: 1) retaining author rights to submit to PMC, 2) submitting the manuscript to PMC or NIH's manuscript submission system, and 3) providing proof of compliance on grant applications. The PI is ultimately responsible for approving manuscript submissions, though an author other than the PI may submit.

An introduction to conducting a systematic literature review for social scien...

rosie.dunne

20131029 Northcutt

ORCID, Inc

Similar to NIH Public Access Policy: Overview (20)

NIHPAP Lecture, part 2 - Complying

NIH Public Access Policy, eRA Commons & My Bbiliography

NIHPAP Lecture, part 1 - About the Policy

NIH Biosketch & Federal Public Access Policies

Guide for My Bibliography and Compliance

The NIH Public Access Policy and Compliance Requirements

NCCMT Spotlight Webinar: MetaQAT

NIH Public Access Policy: Ready to Publish

Applying research in public health

NIH Public Access Policy: You Received NIH Funding

BIOMEDICAL .ppt

Community Training in Evidence Based Practice 3-28-13

NIH Public Access Policy - Neil Thakur (2007)

Nih Public Access Policy

Analytical Methods for Systematic Review Support

Gai Moore, Sax Institute

RDAP14: OSTP Panel NIH’s Update Public Access

NIH Public Access Policy May2008

An introduction to conducting a systematic literature review for social scien...

20131029 Northcutt

More from lynnkysh

Evidence-Based Practice Introduction

lynnkysh

This document provides an overview of evidence-based medicine resources available through the Norris Medical Library. It discusses the steps of evidence-based practice, including formulating a searchable clinical question using PICO. An example scenario is presented where a patient asks if vitamin D and calcium can prevent falls. The scenario is used to demonstrate how to develop a PICO question. Finally, the document reviews the evidence pyramid and different publication types used to evaluate medical evidence.

Psychiatry clerkship

lynnkysh

This document provides resources for clinical reasoning exercises for psychiatry clerks. It discusses formulating clinical research questions using the PICO framework and identifying relevant databases for searching. It also covers applying basic criteria to appraise evidence quality, such as publication type, sample size, methodology. Contact information is provided for the librarian as a resource for more information on search strategies, citation styles, and databases.

Keck Year 2 Evidence Based Medicine - Appraisal Resources

lynnkysh

This document provides an overview of resources for appraising medical information. It discusses tools like ACP Journal Club, DARE, and TheNNT that can help with appraisal. These tools allow for selection, summary, commentary, and dissemination of information. DARE specifically can be found through searching "Other Reviews" in Cochrane. The presentation emphasizes integrating evidence, clinical expertise, and patient values when appraising information.

Keck Year 2 Evidence Based Medicine - Guidelines

lynnkysh

This document discusses evidence-based guidelines and summarizes different types of medical evidence publications from highest to lowest quality. It then presents a clinical scenario about prostate cancer screening and demonstrates how to formulate a question using PICO (Patient, Intervention, Comparison, Outcome). Resources for finding clinical guidelines like PubMed and the National Guidelines Clearinghouse are described. The presentation raises questions about whether clinical information tools should be considered evidence-based medical resources and how to evaluate them.

Keck Year 2 Evidence Based Medicine - Systematic Reviews

lynnkysh

This document distinguishes systematic reviews from standard literature reviews and introduces systematic reviews and meta-analyses. It provides definitions, goals, components, authorship requirements, time commitments, and value of systematic reviews compared to standard literature reviews. The document also reviews how to locate reviews, systematic reviews, and meta-analyses in PubMed and introduces the Cochrane Database of Systematic Reviews.

Keck Year 2 Evidence Based Medicine - Observational Studies and Trials

lynnkysh

The document outlines different types of observational studies and clinical trials used in evidence-based research, including case reports, case series, case-control studies, cohort studies, and randomized controlled trials. It discusses the defining characteristics and relative strengths and weaknesses of each study type. Finally, it introduces PubMed and ClinicalTrials.gov as resources for locating published observational studies and clinical trials.

More from lynnkysh (6)

Evidence-Based Practice Introduction

Psychiatry clerkship

Keck Year 2 Evidence Based Medicine - Appraisal Resources

Keck Year 2 Evidence Based Medicine - Guidelines

Keck Year 2 Evidence Based Medicine - Systematic Reviews

Keck Year 2 Evidence Based Medicine - Observational Studies and Trials

Recently uploaded

acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals

MuskanShingari

Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW

Get New Sim

biomechanics of running. Dr.dhwani.pptx

Dr. Dhwani kawedia

The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.

Helminthiasis or Worm infestation in Children for Nursing students

RAJU B N

Call Girl Pune 7339748667 Vip Call Girls Pune

Mobile Problem

Storyboard on Skin- Innovative Learning (M-pharm) 2nd sem. (Cosmetics)

MuskanShingari

Skin is the largest organ of the human body, serving crucial functions that include protection, sensation, regulation, and synthesis. Structurally, it consists of three main layers: the epidermis, dermis, and hypodermis (subcutaneous layer). 1. **Epidermis**: The outermost layer primarily composed of epithelial cells called keratinocytes. It provides a protective barrier against environmental factors, pathogens, and UV radiation. 2. **Dermis**: Located beneath the epidermis, the dermis contains connective tissue, blood vessels, hair follicles, and sweat glands. It plays a vital role in supporting and nourishing the epidermis, regulating body temperature, and housing sensory receptors for touch, pressure, temperature, and pain. 3. **Hypodermis**: Also known as the subcutaneous layer, it consists of fat and connective tissue that anchors the skin to underlying structures like muscles and bones. It provides insulation, cushioning, and energy storage. Skin performs essential functions such as regulating body temperature through sweat production and blood flow control, synthesizing vitamin D when exposed to sunlight, and serving as a sensory interface with the external environment. Maintaining skin health is crucial for overall well-being, involving proper hygiene, hydration, protection from sun exposure, and avoiding harmful substances. Skin conditions and diseases range from minor irritations to chronic disorders, emphasizing the importance of regular care and medical attention when needed.

2nd-generation Antihistaminic Part I.pptx

Madhumita Dixit

CLASSIFICATION OF H1 ANTIHISTAMINICS- FIRST GENERATION ANTIHISTAMINICS- 1)HIGHLY SEDATIVE-DIPHENHYDRAMINE,DIMENHYDRINATE,PROMETHAZINE,HYDROXYZINE 2)MODERATELY SEDATIVE- PHENARIMINE,CYPROHEPTADINE, MECLIZINE,CINNARIZINE 3)MILD SEDATIVE-CHLORPHENIRAMINE,DEXCHLORPHENIRAMINE TRIPROLIDINE,CLEMASTINE SECOND GENERATION ANTIHISTAMINICS-FEXOFENADINE, LORATADINE,DESLORATADINE,CETIRIZINE,LEVOCETIRIZINE, AZELASTINE,MIZOLASTINE,EBASTINE,RUPATADINE. Mechanism of action of 2nd generation antihistaminics- These drugs competitively antagonize actions of histamine at the H1 receptors. Pharmacological actions- Antagonism of histamine-The H1 antagonists effectively block histamine induced bronchoconstriction, contraction of intestinal and other smooth muscle and triple response especially wheal, flare and itch. Constriction of larger blood vessel by histamine is also antagonized. 2) Antiallergic actions-Many manifestations of immediate hypersensitivity (type I reactions)are suppressed. Urticaria, itching and angioedema are well controlled.3) CNS action-The older antihistamines produce variable degree of CNS depression.But in case of 2nd gen antihistaminics there is less CNS depressant property as these cross BBB to significantly lesser extent. 4) Anticholinergic action- many H1 blockers in addition antagonize muscarinic actions of ACh. BUT IN 2ND gen histaminics there is Higher H1 selectivitiy : no anticholinergic side effects

ENVIRONMENTAL SANITATION in community setting

ShraddhaTamshettiwar

“Environmental sanitation means the art and science of applying sanitary, biological and physical science principles and knowledge to improve and control the environment therein for the protection of the health and welfare of the public”.The overall importance of sanitation are to provide a healthy living environment for everyone, to protect the natural resources (such as surface water, groundwater, soil ), and to provide safety, security and dignity for people when they defecate or urinate .Sanitation refers to public health conditions such as drinking clean water, sewage treatment, etc. All the effective tools and actions that help in keeping the environment clean come under sanitation. Sanitation refers to public health conditions such as drinking clean water, sewage treatment. All the effective tools and actions that help in keeping the environment clean and promotes public health is the necessary in todays life.

anatomy of submandibular region presentation

MalaM67

Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8 - Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)

MuskanShingari

Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient. One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells. Safe methods have been devised to do this, using several viral and non-viral vectors. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria: Protection of transgene or genetic cargo from degradative action of systemic and endonucleases, Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus, Low potential of triggering unwanted immune responses or genotoxicity, Economical and feasible availability for patients . Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells. Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination. There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo. The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.

Nano-gold for Cancer Therapy chemistry investigatory project

SIVAVINAYAKPK

chemistry investigatory project The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications. Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.

RESPIRATORY DISEASES by bhavya kelavadiya

Bhavyakelawadiya

Pharmacology of Drugs for Congestive Heart Failure

Dr. Nikhilkumar Sakle

Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.

Call Girls Lucknow 9024918724 Vip Call Girls Lucknow

nandinirastogi03

Call Girls Goa (india) +91-7426014248 Goa Call Girls

sagarvarma453

Patellar Instability: Diagnosis Management

Dr Nitin Tyagi

pharmacy exam preparation for undergradute students.pptx

AdugnaWari

Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes

Dr. Nikhilkumar Sakle

This presentation gives information on the pharmacology of Prostaglandins, Thromboxanes and Leukotrienes i.e. Eicosanoids. Eicosanoids are signaling molecules derived from polyunsaturated fatty acids like arachidonic acid. They are involved in complex control over inflammation, immunity, and the central nervous system. Eicosanoids are synthesized through the enzymatic oxidation of fatty acids by cyclooxygenase and lipoxygenase enzymes. They have short half-lives and act locally through autocrine and paracrine signaling.

TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...

Donc Test

TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf

Recently uploaded (20)

acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals

Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW

biomechanics of running. Dr.dhwani.pptx

Helminthiasis or Worm infestation in Children for Nursing students

Call Girl Pune 7339748667 Vip Call Girls Pune

Storyboard on Skin- Innovative Learning (M-pharm) 2nd sem. (Cosmetics)

2nd-generation Antihistaminic Part I.pptx

ENVIRONMENTAL SANITATION in community setting

anatomy of submandibular region presentation

Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad

Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)

Nano-gold for Cancer Therapy chemistry investigatory project

RESPIRATORY DISEASES by bhavya kelavadiya

Pharmacology of Drugs for Congestive Heart Failure

Call Girls Lucknow 9024918724 Vip Call Girls Lucknow

Call Girls Goa (india) +91-7426014248 Goa Call Girls

Patellar Instability: Diagnosis Management

pharmacy exam preparation for undergradute students.pptx

Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes

TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...

NIH Public Access Policy: Overview

1. NIH Public Access Policy Overview Norris Medical Library Education and Research Services (323) 442-1483 medlib@usc.edu

2. Outline • What is a PMID? What is a PMCID? • What is the National Institutes of Health (NIH) Public Access Policy? • What are the options for complying with the NIH Public Access Policy? • Who is responsible for this compliance? • How can a manuscript be submitted to PubMed Central? • How do I locate more information about this process? norris.usc.libguides.com/nihcompliance

3. PMID = PubMed Identification Number • Unique number assigned to each article indexed to PubMed • Requires no particular effort from the author norris.usc.libguides.com/nihcompliance

4. PMID = PubMed Identification Number norris.usc.libguides.com/nihcompliance

5. PMCID = PubMed Central Identification Number • PubMed Central • Free full-text archive of the National Institute of Health’s National Library of Medicine • Unique number assigned to each article submitted to PubMed Central • Verifies that articles have been submitted in compliance to NIH Public Access Policy mandate norris.usc.libguides.com/nihcompliance

6. PMCID = PubMed Central Identification Number norris.usc.libguides.com/nihcompliance

7. 2008 Consolidated Appropriations Act "The Director of the National Institutes of Health shall require that all investigators funded by the NIH submit or have submitted for them to the National Library of Medicine’s PubMed Central an electronic version of their final, peer-reviewed manuscripts upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication: Provided, that the NIH shall implement the public access policy in a manner consistent with copyright law.” norris.usc.libguides.com/nihcompliance

8. Applicability • Any manuscript that: • Is peer reviewed; • And, is accepted for publication in a journal1 on or after April 7, 2008; • And, arises from: • Any direct funding2 from an NIH grant or cooperative agreement active in Fiscal Year 2008 or beyond, or; • Any direct funding from an NIH contract signed on or after April 7, 2008, or; • Any direct funding from the NIH Intramural Program, or; • An NIH employee. norris.usc.libguides.com/nihcompliance

9. Who is responsible for compliance? The principal investigator (PI) norris.usc.libguides.com/nihcompliance

10. Method A or B norris.usc.libguides.com/nihcompliance Adapted from Duke University Medical Center Library & Archives Compliance Process Diagram: http://guides.mclibrary.duke.edu/nihpapcompliance Final Peer Reviewed Manuscript PubMed Central (NIH/NLM public access archive) Method A or B: Publisher submits published article

11. Method C norris.usc.libguides.com/nihcompliance Adapted from Duke University Medical Center Library & Archives Compliance Process Diagram: http://guides.mclibrary.duke.edu/nihpapcompliance Final Peer Reviewed Manuscript PubMed Central (NIH/NLM public access archive) Method A or B: Publisher submits published article NIHMS (National Institutes of Health Manuscript Submission system) Method C: PI/Author submits final manuscript to NIHMS PI/Author approves submission

12. Method D norris.usc.libguides.com/nihcompliance Adapted from Duke University Medical Center Library & Archives Compliance Process Diagram: http://guides.mclibrary.duke.edu/nihpapcompliance Final Peer Reviewed Manuscript PubMed Central (NIH/NLM public access archive) Method A or B: Publisher submits published article NIHMS (National Institutes of Health Manuscript Submission system) Method C: PI/Author submits final manuscript to NIHMS PI/Author approves submission Method D: Publisher submits final manuscript to NIHMS

13. More Information • NIH Public Access Policy: publicaccess.nih.gov/ • Policy Details: publicaccess.nih.gov/policy.htm • Submission Methods: publicaccess.nih.gov/submit_process.htm • NIH Manuscript Submission System Help: nihms.nih.gov/help/ norris.usc.libguides.com/nihcompliance

NIH Public Access Policy: Overview

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to NIH Public Access Policy: Overview

Similar to NIH Public Access Policy: Overview (20)

More from lynnkysh

More from lynnkysh (6)

Recently uploaded

Recently uploaded (20)

NIH Public Access Policy: Overview